Sutton Wealth Advisors’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-482
Closed -$10.9K 1398
2022
Q4
$10.9K Buy
482
+127
+36% +$2.87K ﹤0.01% 912
2022
Q3
$9.38K Hold
355
﹤0.01% 908
2022
Q2
$8.77K Sell
355
-175
-33% -$4.37K ﹤0.01% 941
2022
Q1
$17.6K Buy
530
+94
+22% +$2.61K 0.01% 749
2021
Q4
$14.3K Buy
436
+5
+1% +$170 ﹤0.01% 823
2021
Q3
$18.1K Sell
431
-213
-33% -$7.66K 0.01% 726
2021
Q2
$25K Buy
+644
New +$23K 0.01% 635
2020
Q3
Sell
-348
Closed -$12.8K 1244
2020
Q2
$12.8K Buy
348
+208
+149% +$7.75K 0.01% 643
2020
Q1
$4.53K Sell
140
-285
-67% -$11.9K ﹤0.01% 839
2019
Q4
$17.4K Buy
425
+144
+51% +$5.69K 0.01% 657
2019
Q3
$10K Buy
+281
New +$11.4K 0.01% 788
2019
Q2
Sell
-344
Closed -$19.7K 1202
2019
Q1
$19.7K Sell
344
-26
-7% -$1.29K 0.01% 575
2018
Q4
$15.5K Sell
370
-39
-10% -$2.29K 0.01% 609
2018
Q3
$30.9K Buy
409
+29
+8% +$2.09K 0.02% 429
2018
Q2
$27.3K Buy
+380
New +$18.1K 0.02% 471

Other funds holding RGNX